Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vasileios, Ntousopoulos"'
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Orr Green, Vasiliki Rapti, Maria Tsakona, Thomas Konstantinos, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Konstantinos Syrigos, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Garyfalia Poulakou, Mina Gaga, Ronan MacLoughlin, Justin Stebbing, Nadir Arber, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Introduction EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any
Externí odkaz:
https://doaj.org/article/24f5adc7c431420c90c68b1ab0f43b4a
Autor:
Angeliki, Ntineri, Aikaterini, Theodosiadi, Ariadni, Menti, Konstantinos G, Kyriakoulis, Vasileios, Ntousopoulos, Anastasios, Kollias, George S, Stergiou
Publikováno v:
Journal of Hypertension. 41:356-361
A novel automated auscultatory upper arm-cuff blood pressure (BP) monitor (InBody BPBIO480KV) for office use was developed. An electronic stethoscope embedded in the device cuff records the Korotkoff sounds, which are audible to the user and graphica
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, Konstantinos Syrigos, Vasiliki Rapti, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Mina Gaga, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Maria Tsakona, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Open Forum Infectious Diseases. 9
Background EXO-CD24 is a novel inhaled drug of exosomes displaying CD24, a protein with anti-inflammatory properties. We evaluated the safety and potential efficacy of EXO-CD24, in a phase II, randomized, single-blinded clinical trial of EXO-CD24 in
Autor:
Evangelos Oikonomou, Nektarios Souvaliotis, Stamatios Lampsas, Gerasimos Siasos, Garyphallia Poulakou, Panagiotis Theofilis, Theodore G. Papaioannou, Anna-Bettina Haidich, Georgia Tsaousi, Vasileios Ntousopoulos, Vissaria Sakka, Georgios Charalambous, Vasiliki Rapti, Sylvia Raftopoulou, Konstantinos Syrigos, Costas Tsioufis, Dimitris Tousoulis, Manolis Vavuranakis
Publikováno v:
Vascular pharmacology. 144
Coronavirus disease-19 (COVID-19) is implicated by active endotheliitis, and cardiovascular morbidity. The long-COVID-19 syndrome implications in atherosclerosis have not been elucidated yet. We assessed the immediate, intermediate, and long-term eff
Autor:
Konstantinos G Kyriakoulis, Angeliki Ntineri, Aikaterini Theodosiadi, Ariadni Menti, Vasileios Ntousopoulos, Anastasios Kollias, George S Stergiou
Publikováno v:
Journal of Hypertension. 41:e213